Tadalafil
FDA status: FDA has approved products that contain tadalafil, including Adcirca, Opsynvi, Tadliq.
PubMed: 2,986 publications mention Tadalafil, 463 of them trials or reviews. Search PubMed
- Randomized Trial of Macitentan/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension. Grünig E et al. Journal of the American College of Cardiology, 2024. Randomized Controlled Trial. PMID 38267108 · DOI
- Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. Gong B et al. International urology and nephrology, 2017. Meta-Analysis, Systematic Review. PMID 28741090 · DOI
- Tadalafil therapy for pulmonary arterial hypertension. Galiè N et al. Circulation, 2009. Randomized Controlled Trial. PMID 19470885 · DOI
- Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension. Chin KM et al. Journal of the American College of Cardiology, 2021. Clinical Trial, Phase III, Randomized Controlled Trial. PMID 34593120 · DOI
- Treatment of pulmonary arterial hypertension in patients with connective tissue diseases: a systematic review and meta-analysis. Erdogan M et al. Internal and emergency medicine, 2024. Systematic Review, Meta-Analysis. PMID 38378970 · DOI
ClinicalTrials.gov: 290 registered studies. See all studies
MedlinePlus drug information ↗FDA label (DailyMed) ↗RxNorm 358263 ↗PubChem CID 110635 ↗Wikipedia ↗









